Jun 18, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Pivotal Trial Results For Motavizumab Published In Current Issue Of 'Pediatrics'
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2082592" data-attributes="member: 124445"><p>MedImmune announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics. Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by respiratory syncytial virus (RSV) among infants at high risk... <a href="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ihvjA9uOA0A" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/ihvjA9uOA0A/3wZy" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2082592, member: 124445"] MedImmune announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics. Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by respiratory syncytial virus (RSV) among infants at high risk... [URL="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/0/da"][IMG]http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/1/da"][IMG]http://feedads.g.doubleclick.net/~a/Pl_8IbjoyU4812xgwt4UYIhiq74/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/ihvjA9uOA0A[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/ihvjA9uOA0A/3wZy]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top